Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 13

1.

Immune-Checkpoint Protein VISTA Regulates Antitumor Immunity by Controlling Myeloid Cell-Mediated Inflammation and Immunosuppression.

Xu W, Dong J, Zheng Y, Zhou J, Yuan Y, Ta HM, Miller HE, Olson M, Rajasekaran K, Ernstoff MS, Wang D, Malarkannan S, Wang L.

Cancer Immunol Res. 2019 Sep;7(9):1497-1510. doi: 10.1158/2326-6066.CIR-18-0489. Epub 2019 Jul 24.

PMID:
31340983
2.

Targeting Mannitol Metabolism as an Alternative Antimicrobial Strategy Based on the Structure-Function Study of Mannitol-1-Phosphate Dehydrogenase in Staphylococcus aureus.

Nguyen T, Kim T, Ta HM, Yeo WS, Choi J, Mizar P, Lee SS, Bae T, Chaurasia AK, Kim KK.

MBio. 2019 Jul 9;10(4). pii: e02660-18. doi: 10.1128/mBio.02660-18.

3.

Conformational Dynamics of the HIV-Vif Protein Complex.

Ball KA, Chan LM, Stanley DJ, Tierney E, Thapa S, Ta HM, Burton L, Binning JM, Jacobson MP, Gross JD.

Biophys J. 2019 Apr 23;116(8):1432-1445. doi: 10.1016/j.bpj.2019.03.014. Epub 2019 Mar 23.

PMID:
30961890
4.

N-myc downstream-regulated gene 2 protects blood-brain barrier integrity following cerebral ischemia.

Takarada-Iemata M, Yoshikawa A, Ta HM, Okitani N, Nishiuchi T, Aida Y, Kamide T, Hattori T, Ishii H, Tamatani T, Le TM, Roboon J, Kitao Y, Matsuyama T, Nakada M, Hori O.

Glia. 2018 Jul;66(7):1432-1446. doi: 10.1002/glia.23315. Epub 2018 Feb 24.

PMID:
29476556
5.

Ndrg2 deficiency ameliorates neurodegeneration in experimental autoimmune encephalomyelitis.

Le TM, Takarada-Iemata M, Ta HM, Roboon J, Ishii H, Tamatani T, Kitao Y, Hattori T, Hori O.

J Neurochem. 2018 Apr;145(2):139-153. doi: 10.1111/jnc.14294. Epub 2018 Feb 19.

6.

Fab-based inhibitors reveal ubiquitin independent functions for HIV Vif neutralization of APOBEC3 restriction factors.

Binning JM, Smith AM, Hultquist JF, Craik CS, Caretta Cartozo N, Campbell MG, Burton L, La Greca F, McGregor MJ, Ta HM, Bartholomeeusen K, Peterlin BM, Krogan NJ, Sevillano N, Cheng Y, Gross JD.

PLoS Pathog. 2018 Jan 5;14(1):e1006830. doi: 10.1371/journal.ppat.1006830. eCollection 2018 Jan.

7.

Atf6α deficiency suppresses microglial activation and ameliorates pathology of experimental autoimmune encephalomyelitis.

Ta HM, Le TM, Ishii H, Takarada-Iemata M, Hattori T, Hashida K, Yamamoto Y, Mori K, Takahashi R, Kitao Y, Hori O.

J Neurochem. 2016 Dec;139(6):1124-1137. doi: 10.1111/jnc.13714. Epub 2016 Jul 18.

8.

Deletion of Herpud1 Enhances Heme Oxygenase-1 Expression in a Mouse Model of Parkinson's Disease.

Le TM, Hashida K, Ta HM, Takarada-Iemata M, Kokame K, Kitao Y, Hori O.

Parkinsons Dis. 2016;2016:6163934. doi: 10.1155/2016/6163934. Epub 2016 Feb 23.

9.

Design of a RANK-Mimetic Peptide Inhibitor of Osteoclastogenesis with Enhanced RANKL-Binding Affinity.

Hur J, Ghosh A, Kim K, Ta HM, Kim H, Kim N, Hwang HY, Kim KK.

Mol Cells. 2016 Apr 30;39(4):316-21. doi: 10.14348/molcells.2016.2286. Epub 2016 Feb 26.

10.

Deletion of Atf6α impairs astroglial activation and enhances neuronal death following brain ischemia in mice.

Yoshikawa A, Kamide T, Hashida K, Ta HM, Inahata Y, Takarada-Iemata M, Hattori T, Mori K, Takahashi R, Matsuyama T, Hayashi Y, Kitao Y, Hori O.

J Neurochem. 2015 Feb;132(3):342-53. doi: 10.1111/jnc.12981. Epub 2015 Jan 6.

11.

Structure-based elucidation of the regulatory mechanism for aminopeptidase activity.

Ta HM, Bae S, Han S, Song J, Ahn TK, Hohng S, Lee S, Kim KK.

Acta Crystallogr D Biol Crystallogr. 2013 Sep;69(Pt 9):1738-47. doi: 10.1107/S0907444913012651. Epub 2013 Aug 15.

PMID:
23999297
12.

Structure-based development of a receptor activator of nuclear factor-kappaB ligand (RANKL) inhibitor peptide and molecular basis for osteopetrosis.

Ta HM, Nguyen GT, Jin HM, Choi J, Park H, Kim N, Hwang HY, Kim KK.

Proc Natl Acad Sci U S A. 2010 Nov 23;107(47):20281-6. doi: 10.1073/pnas.1011686107. Epub 2010 Nov 8. Erratum in: Proc Natl Acad Sci U S A. 2011 Jun 14;108(24):10022.

13.

Supplemental Content

Support Center